Although cell counting revealed that the numbers of NeuN positive cells were equivalent across experimental groups on day 1 (Figure 3I), on day 7 NeuN positive cells were significantly more numerous in the HBO-PC group as compared to unpreconditioned ischemia and HBO-PC pretreated with a proteasome inhibitor (Figure 3J). This evidence concerns the gene RBFOX3 and ischemia.